Osteoporosis News

BALTIMORE —Combined denosumab and teriparatide demonstrated superior efficacy compared with either treatment alone for patients at high risk for fractures, according to data presented at ASBMR 2013.

BALTIMORE — Higher concentrations of inflammatory factors were associated with higher risk for hip fracture, according to study results presented here.

BALTIMORE — The initial reports from the extension of the FREEDOM trial show continued efficacy of denosumab for increasing bone mineral density and prevention of fracture in patients receiving the drug in the long term and those switched over from placebo treatment.

SAN FRANCISCO — Researchers found a low risk of mechanical failure in patients with osteoporosis who had distal radius fracture fixation with a volar locking plate, according to a presenter here.

BALTIMORE — In a meta-analysis of randomized, controlled trials, calcium plus vitamin D only modestly reduced fracture risk and was not associated with increased risk for cardiovascular disease outcomes, according to data presented by Jacqueline R. Center, MBBS, PhD, FRACP, at ASBMR 2013.

BALTIMORE — Muscle power and force could contribute to cortical bone strength via distinct mechanisms, according to data presented by Sarah A. Hardcastle, MBChB, BSc, MRCP, clinical research fellow at the University of Bristol in the United Kingdom, here at ASBMR 2013.

BALTIMORE — Men with sarcopenia and osteopenia/osteoporosis had a threefold greater risk for fracture compared with men who only had one of the diseases, according to data presented at ASBMR 2013.

The use of trabecular bone scores improved the performance of lumbar spine areal bone mineral density in the prediction of vertebral osteoporotic fractures in postmenopausal women, according to this study.

Researchers from Rome who evaluated elderly patients at an outpatient spine clinic found examining these patients’ pain-related behavior clinically could predict the presence of an osteoporotic vertebral compression fracture, according to results of this study.

Conducting a bone mineral density screening every 2 years to quantify fracture risk may not be necessary in adults aged at least 75 years who have not been treated for osteoporosis, according to recent data.